Hims & Hers Shares Plunge 14% on FTC Lawsuit; Hagens Berman Probes Compliance
Hims & Hers Health's stock fell about 14% after the FTC sued the company over alleged privacy and billing violations. Hagens Berman is investigating corporate compliance and potential investor ramifications. The case underscores regulatory risks facing fast-growing health-tech firms.